• Industry News
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

Healthcare Reform - 2013

Article

2011  /  2012  /  2013  / 2014  /  2015

2013

Increased Medicaid funding
New funding available to state Medicaid programs choosing to cover preventative services for patients at little to no cost; goal to expand reach of preventative care efforts.
Effective Jan. 1, 2013

Stage 2 of ‘meaningful use’ begins
Stage 2 of CMS’ EHR Incentive Program starts, requiring eligible professionals and hospitals to prove “meaningful use” for federal payments.
Effective January 2013
UPDATE: In April 2012, CMS released proposed clinical quality measures for the Stage 2 requirements; in February 2012, CMS announced it would extend attestation for Stage 1 rules into 2013 and Stage 2 attestation will begin in 2014.

‘Bundled’ payments
National pilot program established to encourage teamwork among hospitals, physicians, and other providers to coordinate and improve care; team would be paid a “bundled” flat rate for an episode of care versus current fee-for-service system by Medicare.
Effective Jan. 1, 2013 at the latest

Medicaid payment boost
States to pay primary-care physicians no less than 100 percent of Medicare payment rates in 2013, 2014 for services; increase is fully funded.
Effective Jan. 1, 2013

ICD-10 implementation
Claims for services to CMS must use ICD-10 codes for medical diagnosis and impatient procedures; CPT codes for outpatient services will continue to be used.
Effective Oct. 1, 2013
UPDATE: HHS announced in April 2012 it would delay compliance for ICD-10 from Oct. 1, 2013 to Oct. 1, 2014.

Related Videos
The importance of vaccination
The fear of inflation and recession
Protecting your practice
Protecting your home, business while on vacation
Protecting your assets during the 100 deadly days
Payment issues on the horizon
The future of Medicare payments
MGMA comments on automation of prior authorizations
The burden of prior authorizations
Strategies for today's markets
© 2024 MJH Life Sciences

All rights reserved.